Celularity Inc.

NASDAQ:CELU

2.56 (USD) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Revenue 12.1123.7862.9383.9354.1294.1353.7765.9354.85710.6223.1972.663.2433.3553.4724.2085.151000
Cost of Revenue 9.6093.6021.04525.6785.2477.2133.1794.0264.662.3111.441.2421.171.0330.2080.2420.5640.2020.1150
Gross Profit 2.5030.1841.893-21.743-1.118-3.0780.5971.9090.1978.3111.7571.4182.0732.3223.2643.9664.587-0.202-0.1150
Gross Profit Ratio 0.2070.0490.644-5.526-0.271-0.7440.1580.3220.0410.7820.550.5330.6390.6920.940.9430.89000
Reseach & Development Expenses -0.2725.1828.60416.95110.9920.35125.34921.67324.68723.76522.91116.9913.92411.21715.80411.76212.75000
General & Administrative Expenses 13.02400018.91700012.9560000.2427.6836.5560.2420.2470.2020.1150
Selling & Marketing Expenses 0.0440000.1630000.2520005.7310.6441.0301.158000
SG&A 13.06810.74812.82613.93419.0814.90715.57416.4613.20821.64428.8637.6265.9738.3277.5860.2420.2470.2020.1150
Other Expenses -2.5861.141-4.3010.5410.5530.5530.5460.54134.429-0.109-3.178-0.027-0.0030.5040.20800000
Operating Expenses -10.81216.72621.97631.42630.62335.81141.46938.67437.89545.96252.3225.15720.44820.3270.2080.2420.2470.2020.1150
Operating Income 13.315-99.256-42.476-63.8717.485-5.646-40.872-36.765-14.9510.898-60.611-44.39511.055-4.806-0.208-0.242-0.247-0.202-0.115-0
Operating Income Ratio 1.099-26.217-14.457-16.2314.235-1.365-10.824-6.195-3.0781.026-18.959-16.693.409-1.432-0.06-0.057-0.048000
Total Other Income Expenses Net -3.21-76.386-26.828-0.1476.96210.42888.715-26.10234.42988.377-13.226-57.18822.806-27.691-12.4381.5391.2061.6210.9190
Income Before Tax 9.557-93.876-47.949-64.01724.4474.78247.843-62.867-4.0249.938-64.477-81.5393.841-46.31-12.1481.2970.9591.4190.803-0
Income Before Tax Ratio 0.789-24.796-16.32-16.2695.9211.15612.67-10.593-0.8284.701-20.168-30.6541.184-13.803-3.4990.3080.186000
Income Tax Expense 0.012.112-3.1970.4240.013-0.0170.01726.1020.020.7340.0440.044-0.0690.015-0.0380.2730.2020.2980.169-0.04
Net Income 9.547-93.876-47.949-64.01724.4344.79947.826-62.867-4.03949.938-64.477-81.5393.91-46.325-12.111.0250.7571.1210.635-0
Net Income Ratio 0.788-24.796-16.32-16.2695.9181.16112.666-10.593-0.8324.701-20.168-30.6541.206-13.808-3.4880.2440.147000
EPS 0.54-5-2.72-4.121.670.343.41-4.82-0.334.69-5.26-6.660.032-7.56-1.980.430.320.470.27-0
EPS Diluted 0.54-4.98-2.72-4.121.240.33.2-4.82-0.334-5.26-6.660.032-7.56-1.980.430.320.470.27-0
EBITDA 13.14-13.035-21.996-52.411-32.836-35.4-38.097-34.802-3.261-37.152-53.066-21.69-16.411-16.62612.231.2970.9591.4190.803-0
EBITDA Ratio 1.085-3.443-7.487-13.319-7.953-8.561-10.089-5.864-0.671-3.498-16.599-8.154-5.06-4.9563.5220.3080.186000